Kristof Rudolf A, Rother Maria, Neuloh Georg, Klingmüller Dietrich
Department of Neurosurgery, University of Bonn, Germany.
J Neurosurg. 2009 Sep;111(3):555-62. doi: 10.3171/2008.9.JNS08191.
The authors prospectively studied the incidence, spectrum of clinical manifestations, course, and risk factors of water and electrolyte disturbances (WEDs) following transsphenoidal pituitary adenoma surgery.
From the preoperative day to the 14th postoperative day, 57 successive patients undergoing transsphenoidal adenomectomy were monitored daily for body weight, balance of fluids, serum electrolytes, plasma osmolality, plasma antidiuretic hormone (ADH) levels, urinary sodium excretion, urinary osmolality, and subjective sensation of thirst. The type of adenoma operated on and the intraoperative manipulation of the neurohypophysis were also recorded.
Fifty-seven patients (mean age 55 years, 61.4% females) harbored 30 clinically hormone-inactive and 27 hormone-secreting pituitary adenomas. Postoperative WED occurred in 75.4% of the patients: in 38.5% as isolated diabetes insipidus (DI); in 21% as isolated hyponatremia; and in 15.7% as combined DI-hyponatremia. The maximum of medians of diuresis (5.750 L) in patients with isolated DI occurred on postoperative Day 2. Nadir of medians of hyponatremia (132 mmol/L) in patients with isolated hyponatremia occurred on postoperative Day 9. In patients with combined DI-hyponatremia, maximum of medians of diuresis (5.775 L) occurred on the 2nd day and nadir of medians of hyponatremia (130 mmol/L) on the 10th postoperative day. Altogether, 8.7% of the patients had to be treated with desmopressin because of DI persisting for >3 months. Of all the patients with hyponatremia, 42.8% were treated by transient fluid-intake restriction due to an IH of <130 mmol/L with or without clinical symptomatology. Transient acute renal failure occurred in one of these patients. Generally, the occurrence of postoperative WEDs was linked to the intraoperative manipulation of the neurohypophysis. Increased thirst correlated significantly with DI (p=0.001 and 0.02, respectively) and decreased thirst with the hyponatremic episode in patients with combined DI-hyponatremia (p=0.003). Decreased urine osmolality correlated significantly with the presence of DI (p=0.023). Electrolyte-free water clearance and urinary Na+ excretion were not correlated with DI and hyponatremia. Antidiuretic hormone was not suppressed during hyponatremia.
Water and electrolyte disturbances occurred in the majority of patients undergoing transsphenoidal adenomectomy and were usually transient. Diabetes insipidus is more frequent than hyponatremia. Diabetes insipidus usually occurs during the 1st postoperative day and resolves in the majority of cases within 10 days. In few patients, DI may persist and require therapy with ADH analogs. Hyponatremia usually occurs at the end of the 1st postoperative week and resolves in most cases within 5 days. Very few patients will need treatment other than fluid-intake restriction to avoid serious complications. Thus, careful monitoring of the WEDs in patients undergoing transsphenoidal pituitary adenoma surgery is mandatory for the first 10 postoperative days.
作者前瞻性研究了经蝶窦垂体腺瘤手术后水和电解质紊乱(WEDs)的发生率、临床表现谱、病程及危险因素。
从术前一天至术后第14天,对57例连续接受经蝶窦腺瘤切除术的患者每日监测体重、液体平衡、血清电解质、血浆渗透压、血浆抗利尿激素(ADH)水平、尿钠排泄、尿渗透压及口渴主观感觉。同时记录所手术的腺瘤类型及术中对神经垂体的操作情况。
57例患者(平均年龄55岁,61.4%为女性),其中30例为临床无激素活性垂体腺瘤,27例为分泌激素的垂体腺瘤。术后WEDs发生于75.4%的患者:38.5%为单纯性尿崩症(DI);21%为单纯性低钠血症;15.7%为DI合并低钠血症。单纯性DI患者利尿中位数最大值(5.750L)出现在术后第2天。单纯性低钠血症患者低钠血症中位数最低点(132mmol/L)出现在术后第9天。DI合并低钠血症患者中,利尿中位数最大值(5.775L)出现在第2天,低钠血症中位数最低点(130mmol/L)出现在术后第10天。总共8.7%的患者因DI持续超过3个月而需用去氨加压素治疗。在所有低钠血症患者中,42.8%因血钠<130mmol/L且有或无临床症状而接受短暂液体摄入限制治疗。其中1例患者发生短暂急性肾衰竭。一般来说,术后WEDs的发生与术中对神经垂体的操作有关。口渴增加与DI显著相关(分别为p=0.001和0.02),而在DI合并低钠血症患者中口渴减少与低钠血症发作相关(p=0.003)。尿渗透压降低与DI的存在显著相关(p=0.023)。无电解质水清除率和尿钠排泄与DI及低钠血症无关。低钠血症期间抗利尿激素未被抑制。
大多数经蝶窦腺瘤切除术患者发生水和电解质紊乱,且通常为短暂性。尿崩症比低钠血症更常见。尿崩症通常发生在术后第1天,大多数病例在10天内缓解。少数患者DI可能持续存在并需要用ADH类似物治疗。低钠血症通常发生在术后第1周结束时,大多数病例在5天内缓解。极少数患者除液体摄入限制外还需要其他治疗以避免严重并发症。因此,对接受经蝶窦垂体腺瘤手术的患者在术后前10天必须仔细监测WEDs。